Impact of mother donor, peripheral blood stem cells and measurable residual disease on outcomes after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide in children with acute leukaemia
Vanderson Rocha, Leonardo Javier Arcuri, Adriana Seber, Vergílio Antônio Rensi Colturato, Victor Gottardello Zecchin, Cilmara Kuwahara, Samantha Nichele, Roseane Vasconcelos Gouveia, Juliana Folloni Fernandes, Antônio Vaz de Macedo, Rita de Cássia Barbosa da Silva Tavares, Liane Esteves Daudt, Mair Pedro de Souza, Luiz Guilherme Darrigo, Neysimélia Costa Villela, Lívia Mariano, Valéria Cortez Ginani, Angela Maria Dias Zanette, Gisele Loth, Alessandra Araújo Gomes, Nelson Hamerschlak, Mary E.D. Flowers, Carmem Bonfim
Topics & Concepts
MedicineCyclophosphamideInternal medicineCumulative incidenceTransplantationHematopoietic stem cell transplantationGraft-versus-host diseaseGastroenterologyBone marrowOncologySurgeryChemotherapyHematopoietic Stem Cell TransplantationChildhood Cancer Survivors' Quality of LifeAcute Lymphoblastic Leukemia research